PDCD1 and hepatocellular carcinoma: The efficacies of HAIC with TKIs and TKIs with PD-1 inhibitors were assessed in patients with HCC based on their liver function [15–18]; however, the efficacy of combined HAIC, TKIs, and PD-1 inhibitors in u-HCC has not been reported.